SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886163-19-000029
Filing Date
2019-02-07
Accepted
2019-02-07 18:19:51
Documents
1
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 5  
1 PRIMARY DOCUMENT edgardoc.xml 5 2995
  Complete submission text file 0000886163-19-000029.txt   4366
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10275 SCIENCE CENTER DR SAN DIEGO CA 92121
Business Address
KOZARICH JOHN W (Reporting) CIK: 0001223000 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-33093 | Film No.: 19576684